The retrospective study analyzed SEER data from 2001 through 2009, and found that the annual CAD prevalence among Medicare screening mammograms increased from 3.5% to 79.7%.
When used during mammograms on women aged 65 and older, computer-aided detection (CAD) leads to more diagnostic intervention, including biopsy, and increases the detection of in situ breast tumors, a new study shows.
"Because in situ tumors often neither grow nor progress, CAD may be leading to a lot of unnecessary breast surgery and radiation in older women who don't really have ," Dr. Joshua J. Fenton, of the University of California Davis, told Reuters Health by email.
Medicare has reimbursed CAD during screening mammography since 2001. In a prior study, Dr. Fenton and colleagues found that CAD use increases the rate of false-positive findings on screening mammography and the detection of ductal carcinoma in situ (DCIS).
Complete report on Medscape: http://bit.ly/108L6LO
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More